Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

OriginalsprogEngelsk
TidsskriftLeukemia and Lymphoma
Vol/bind60
Udgave nummer13
Sider (fra-til)3296-3299
ISSN1042-8194
DOI
StatusUdgivet - 2019

ID: 226877207